Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment pl… Read more
Market Cap & Net Worth: Pheton Holdings Ltd Class A Ordinary Shares (PTHL)
Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) has a market capitalization of $2.89 Million ($2.89 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #33849 globally and #11046 in its home market, demonstrating a -12.41% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pheton Holdings Ltd Class A Ordinary Shares's stock price $0.31 by its total outstanding shares 9382000 (9.38 Million).
Pheton Holdings Ltd Class A Ordinary Shares Market Cap History: 2024 to 2026
Pheton Holdings Ltd Class A Ordinary Shares's market capitalization history from 2024 to 2026. Data shows change from $41.37 Million to $2.89 Million (-80.58% CAGR).
Index Memberships
Pheton Holdings Ltd Class A Ordinary Shares is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #852 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2692 of 3165 |
Weight: Pheton Holdings Ltd Class A Ordinary Shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Pheton Holdings Ltd Class A Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pheton Holdings Ltd Class A Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
92.31x
Pheton Holdings Ltd Class A Ordinary Shares's market cap is 92.31 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $41.37 Million | $448.20K | -$661.00K | 92.31x | N/A |
Competitor Companies of PTHL by Market Capitalization
Companies near Pheton Holdings Ltd Class A Ordinary Shares in the global market cap rankings as of March 18, 2026.
Key companies related to Pheton Holdings Ltd Class A Ordinary Shares by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Pheton Holdings Ltd Class A Ordinary Shares Historical Marketcap From 2024 to 2026
Between 2024 and today, Pheton Holdings Ltd Class A Ordinary Shares's market cap moved from $41.37 Million to $ 2.89 Million, with a yearly change of -80.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.89 Million | -26.69% |
| 2025 | $3.95 Million | -90.46% |
| 2024 | $41.37 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Pheton Holdings Ltd Class A Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.89 Million USD |
| MoneyControl | $2.89 Million USD |
| MarketWatch | $2.89 Million USD |
| marketcap.company | $2.89 Million USD |
| Reuters | $2.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.